top of page
Carcell welcomes Prof. Harvey Lodish as Chair of its Scientific Advisory Board
SINGAPORE and SHANGHAI, Dec. 19, 2022 -- Carcell Biopharma ("Carcell"), an EVX Ventures company, is pleased to announce Prof. Harvey...
Dec 20, 2022
Carmine Therapeutics Announces First Close of Series A to Develop Non-viral Gene Therapy
Cambridge, MA, October 13, 2022 -- Carmine Therapeutics (“Carmine”), an EVX founded biotech company and emerging leader in non-viral gene...
Oct 13, 2022
Cargene Biopharma Welcomes Kathy He as CEO
Cargene Biopharma Welcomes Kathy He as CEO, to Accelerate Novel Oligonucleotide Therapeutics Development SINGAPORE, BOSTON and SHANGHAI...
Jun 28, 2022
EVX Ventures announces the official opening of EVX Nexus, its life sciences startup launchpad
SINGAPORE – 27 May 2022. EVX Ventures (“EVX”), a life sciences venture builder headquartered in Singapore with operations in Boston and...
Jun 1, 2022
EVX Ventures | 2021 Year In Review
We are absolutely thrilled to share EVX Ventures’ 2021 Year in Review. Check out our latest Year in Review to learn more:
Jan 28, 2022
Carcell Biopharma closes an oversubscribed financing round led by Hyfinity Investments
Advancing the next generation of cell and gene therapies via a “platform of platforms” model SINGAPORE, Nov. 1, 2021 /PRNewswire/ --...
Nov 2, 2021
bottom of page